Drug for type 2 diabetes provides significant benefits to type 1 diabetic patientsSeptember 14, 2017
BUFFALO, N.Y. -- A majority of patients with Type 1 diabetes who were treated with dapagliflozin, a Type 2 diabetes medicine, had a significant decline in their blood sugar levels, according to a new study published in The Lancet Diabetes and Endocrinology. The results are being presented today by the University at Buffalo researcher who led the study at the annual meeting of the European Association for the Study of Diabetes in Lisbon.
Called DEPICT-1, which stands for Dapagliflozin in Patients with Inadequately Controlled Type 1 diabetes, the 24-week study was the first global multicenter investigation of dapagliflozin to test its efficacy and safety in Type 1 diabetes. The double-blind, randomized, three-arm, phase 3 multicenter study was conducted at 143 sites in 17 countries, including the U.S. It was funded by AstraZeneca and Bristol-Myers Squibb, the companies that partnered to develop dapagliflozin.
Participants were 833 patients aged 18-75 who had inadequately controlled blood sugars with a mean baseline hemoglobin A1C (HbA1c) -- a measure of sugar in the blood -- level of 8.53. A1C levels for Type 1 diabetics are considered optimal when they are under seven.
Adjunct to insulin
The results demonstrate that when this drug, a sodium glucose cotransporter-2 inhibitor (SGLT-2) was administered as an adjunct therapy in addition to the insulin that patients with Type 1 diabetes need to survive, it significantly improved outcomes.
"Our paper provides the initial signal that dapagliflozin is safe and effective in patients with Type 1 diabetes and is a promising adjunct treatment to insulin to improve glycemic control," said senior author Paresh Dandona, MD, PhD, SUNY Distinguished Professor and chief of endocrinology, diabetes and metabolism in the Department of Medicine in the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo.
"The 24-week results from DEPICT-1 are important as they represent the first Phase 3 trial in Type 1 diabetes of the newer, selective SGLT-2 class of diabetes medicines as an oral adjunct to insulin," he said.
In the study, approximately half of the patients taking dapagliflozin reduced their A1C levels by more than 0.5 percent without experiencing severe drops in blood sugar (hypoglycemia). Dandona explained that any fall in HbA1c of around .5 percent is considered significant and can lead to licensing of a drug as an antidiabetic agent. He noted, however, that the findings will need further confirmation before the drug can be licensed by the FDA for use in Type 1 diabetes.
Better control in Type 1 diabetes
"Treating the millions of patients living with Type 1 diabetes while also managing the complications associated with the disease remains a daunting challenge," said Dandona, who sees patients through UBMD Internal Medicine at the Diabetes and Endocrinology Center of Western New York, which is where the five Buffalo patients in the study were treated.
He is renowned for his diabetes and metabolic research, particularly into new treatments that can be used in addition to insulin, to help patients with Type 1 diabetes achieve better blood sugar control. He has led the field globally since his published work on liraglutide patients with Type 1 diabetes in 2011.
In 2011, Dandona published an observational study that found that another drug for Type 2 diabetes, liraglutide, could help treat Type 1 diabetes.
"Our key paper in 2011 has led to other drugs being considered for use in Type 1 diabetes," he said. "We have been pioneers in conceptualizing new ways to help Type 1 diabetes patients achieve better outcomes with new therapies."
Dandona pointed out that until these recent developments, there hadn't been another significant treatment developed for Type 1 diabetes since the discovery of insulin in the 1920s.
Even Type 1 patients with good glycemic control experience what he calls "glycemic excursions," pronounced swings from hyperglycemic to hypoglycemic, motivating him and his colleagues to conduct groundbreaking research aimed at discovering non-insulin drugs that can help improve blood sugar control.
An interesting aspect of the current study is that contrary to Dandona's earlier pilot study with dapagliflozin, there was no finding of ketoacidosis, a dangerous complication that occurs when acids and substances called ketones build up in the blood due to lack of insulin. "We found out that any reduction of insulin dose greater than 20 percent, or the absence of a meal and missing the insulin dose, or the significant intake of alcohol makes you more vulnerable to ketoacidosis," he explained, noting that since these issues were avoided in the DEPICT-1 study, no increase in ketoacidosis was observed.
Dandona and his co-authors are awaiting the final results of the DEPICT-1 patients at 56 weeks. "If the outcomes are sustained or better at that time, and if a parallel study, DEPICT-2, confirms this, there will likely be an application to the FDA for licensing the drug for use in Type 1 diabetes," he said.
University at Buffalo
Related Diabetes Articles:
There has been no known link between diabetes and vitamin A -- until now.
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like symptoms.
A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40 percent over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.
Related Diabetes Reading:
Bright Spots & Landmines: The Diabetes Guide I Wish Someone Had Handed Me
by Adam Brown (Author), Kelly L. Close (Foreword)
Adam Brown’s acclaimed diaTribe column, Adam’s Corner, has brought life-transforming diabetes tips to over 600,000 people since 2013. In this highly actionable guide, he shares the food, mindset, exercise, and sleep strategies that have had the biggest positive impact on his diabetes – and hopefully yours too! Bright Spots & Landmines is filled with hundreds of effective diabetes tips, questions, and shortcuts, including what to eat to minimize blood sugar swings; helpful strategies to feel less stressed, guilty, and burned out; and simple ways to improve exercise and... View Details
The End of Diabetes: The Eat to Live Plan to Prevent and Reverse Diabetes
by Dr. Joel Fuhrman (Author)
The New York Times bestselling author of Eat to Live and Super Immunity and one of the country’s leading experts on preventive medicine offers a scientifically proven, practical program to prevent and reverse diabetes—without drugs.
At last, a breakthrough program to combat the rising diabetes epidemic and help millions of diabetics, as well as those suffering with high blood pressure and heart disease. Joel Fuhrman, M.D. Research director of the Nutritional Research Foundation, shows you how to live a long, healthy, and happy life—disease free. He... View Details
Diabetes For Dummies
by Alan L. Rubin (Author)
The straight facts on treating diabetes successfully
With diabetes now considered pandemic throughout the world, there have been enormous advances in the field. Now significantly revised and updated, this new edition of Diabetes For Dummies includes the latest information on diabetes medications and monitoring equipment, new findings about treating diabetes in the young and elderly, new ways to diagnose and treat long- and short-term complications, updated nutritional guidelines, new tools for measuring blood sugar and delivering insulin to the body, and much more.
There's... View Details
The Official Pocket Guide to Diabetic Food Choices
by American Diabetes Association ADA (Author)
Completely updated to match the newest edition of Choose Your Foods: Food Lists for Diabetes Meal Planning, this pocket-sized guide is now better and more complete than ever.
Every day and at every meal, millions of people use the food list system to plan meals, make healthier choices, and better estimate portions. This proven system is the most popular approach to diabetes meal planning and has been used by dietitians, diabetes educators, and millions of people with diabetes for more than 70 years. This portable version of the Food Lists takes all of the information from... View Details
Choose Your Foods: Food Lists for Diabetes
by American Diabetes Association (Author)
The standard for diabetes meal planning for over 60 years, this edition features updated carbohydrate, protein, and fat information for a wide variety of foods and beverages and replaces exchange terminology with choices. Includes tips on exercise, reading food labels, and a glossary of diabetes related terms. View Details
The First Year: Type 2 Diabetes: An Essential Guide for the Newly Diagnosed (The Complete First Year)
by Gretchen Becker (Author), Allison B. Goldfine (Author)
The go-to step-by-step guide that walks you through the first days, weeks, and months of your diagnosis–fully revised and updated
Gretchen Becker was diagnosed with type 2 diabetes in 1996; over the past twenty years, she has educated herself on every aspect of the condition by reading medical texts and journals, talking with doctors, and corresponding with others who have type 2, sharing everything she's learned in a comprehensive, easy-to-use guide. Now in its third edition, The First Year: Type 2 Diabetes takes you through everything you need to learn and do in your... View Details
Diabetic Living Diabetes Meals by the Plate: 90 Low-Carb Meals to Mix & Match
by Diabetic Living Editors (Author)
An easy, graphic guide to planning delicious, diabetes-friendly meals This innovative, graphic cookbook offers the easiest and most flavorful way to build complete meals that are diabetes-friendly and delicious. Sidestepping complex programs that turn meal-planning into work, the 90 complete meals in Diabetes Meals by the Plate follow the Plate Method—a simple approach to eating the right foods in proper amounts by filling your plate with one half nonstarchy vegetables, one quarter protein, and one quarter starch. A clever photo style showing every meal in its three... View Details
The Prediabetes Diet Plan: How to Reverse Prediabetes and Prevent Diabetes through Healthy Eating and Exercise
by Hillary Wright (Author)
A practical, empowering guide to managing and reversing prediabetes through diet and exercise, from a registered dietitian.
Affecting 79 million Americans, prediabetes often develops into full-blown type 2 diabetes, one of the leading causes of death in the United States. Increasingly diagnosed by doctors, prediabetes is a condition in which blood sugar levels are elevated, but not yet high enough to be labeled diabetes. While diabetes cannot be cured, prediabetes can be reversed, so it is critical to take action at an early stage.
In straightforward, jargon-free... View Details
American Diabetes Association Complete Guide to Diabetes: The Ultimate Home Reference from the Diabetes Experts
by American Diabetes Association (Author)
The American Diabetes Association—the nation's leading health organization supporting diabetes research, information, and advocacy—has completely revised this comprehensive home reference to provide all the information a person needs to live an active, healthy life with diabetes. Now in its fifth edition, this extensive resource contains information on the best self-care techniques and the latest medical advances. For people with diabetes, this extraordinary guide will answer any question. Topics include the latest on self-care for type 1, type 2, and gestational diabetes; new types of... View Details
Diabetes Meal Planning Made Easy
by Hope S. Warshaw R.D. (Author)
Diabetes Meal Planning Made Easy takes the guesswork out of planning meals by teaching you how to eat healthy, one step at a time. A perennial best-seller from the American Diabetes Association, this book has sold more than 80,000 copies and been the go-to diabetes nutrition guidebook for more than 15 years.
The all-new 5th edition has been streamlined, updated, and improved to represent the latest ways people treat their diabetes meal plans. Updates include:
Revised food groups to reflect changes in nutrition science.
Updated food lists for comprehensive meal... View Details